Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jan;8(1):167-73.
doi: 10.1002/j.1460-2075.1989.tb03361.x.

HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor

Affiliations

HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor

J Lee et al. EMBO J. 1989 Jan.

Abstract

We have investigated the biological function of an unidentified human growth factor, the ligand of the putative HER2 receptor, by characterizing the signalling properties of its receptor. HER2 (or c-erbB-2), the human homolog of the rat neu proto-oncogene, encodes a transmembrane glycoprotein of the tyrosine kinase family that appears to play an important role in human breast carcinoma. Since a potential ligand for HER2 has not yet been identified, it has been difficult to analyze the biochemical properties and biological function of this cell surface protein. For this reason, we replaced the HER2 extracellular domain with the closely related ligand binding domain sequences of the epidermal growth factor (EGF) receptor, and examined the ligand-induced biological signalling potential of this chimeric HER1-2 protein. This HER1-2 receptor is targetted to the cell surface of transfected NIH 3T3 cells, forms high and low affinity binding sites, and generates normal mitogenic and cell transforming signals upon interaction with EGF or TGF alpha. The constitutive activation of wild-type HER2 in transfected NIH 3T3 cells suggests the possibility that these cells synthesize the as yet unidentified HER2 ligand and activate HER2 by an autocrine mechanism.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Cell Biol. 1988 Jun;8(6):2302-8 - PubMed
    1. Cell. 1985 Mar;40(3):619-25 - PubMed
    1. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1037-43 - PubMed
    1. Nature. 1986 Nov 6-12;324(6092):68-70 - PubMed
    1. Science. 1987 Jul 10;237(4811):178-82 - PubMed

MeSH terms